Scribe Therapeutics

📍 Alameda, United States👥 109 employees💰 Last funded 2021
Biotechnology Research🌐 scribetx.com
Website LinkedIn
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Scribe Therapeutics?
Scribe Therapeutics has 2 investors on record on gritt.io.
When did Scribe Therapeutics last raise funding?
The most recent investment in Scribe Therapeutics recorded on gritt.io was in 2021.
What industry is Scribe Therapeutics in?
Scribe Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scribe Therapeutics based?
Scribe Therapeutics is headquartered in Alameda, United States.